Study to Evaluate the Diagnostic Performance of of MAGENTIQ-COLO During Colonoscopy.

Launched by MAGENTIQ EYE LTD · Aug 21, 2024

Keywords

ClinConnect Summary

This clinical trial, called MAGENTIQ-COLO, is designed to test a new technology that helps doctors better identify and measure polyps during colonoscopy procedures. A colonoscopy is a test that lets doctors look inside the colon to check for any abnormal growths, which can sometimes lead to cancer. The goal of this study is to see how well this new technology works in helping doctors make accurate diagnoses during routine screenings or follow-up exams.

To participate in the trial, you need to be between 45 and 80 years old and scheduled for a non-invasive screening or surveillance colonoscopy. However, certain conditions may prevent you from joining, such as having known polyps from a previous exam, certain bowel diseases, or if you're pregnant. If you decide to participate, you’ll be helping researchers understand how this new tool can improve the detection of polyps and potentially enhance patient care in the future. Keep in mind that this study is not yet recruiting participants.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Individuals aged ≥45 - ≤80 years old, who are scheduled for non-iFOBT screening or surveillance colonoscopy.
• Exclusion Criteria:
• • 1. In situ polyps with known histology detected in a previous colonoscopy.
• • 2. No colorectal polyps detected during colonoscopy.
• • 3. Known or suspected inflammatory bowel disease.
• • 4. Polyposis syndrome (e.g., familial adenomatous polyposis, serrated polyposis).
• • 5. Non-hereditary polyposis syndromes (e.g. Lynch syndrome).
• • 6. History of chemotherapy or radiation therapy for colorectal lesions.
• • 7. Pregnancy.
• • 8. Has a referral for therapeutic procedure (i.e., endoscopic mucosal resection, intervention to stop a lower gastro-intestinal bleeding, etc.).
• • 9. Inability to undergo polypectomy (e.g., incorrect continued use of anticoagulants, comorbidities) or patient refusal, as assessed by the endoscopist.
• • 10. Inability to provide informed consent.